Page last updated: 2024-08-24

mizolastine and Rhinitis, Allergic, Seasonal

mizolastine has been researched along with Rhinitis, Allergic, Seasonal in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (53.85)18.2507
2000's6 (46.15)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ciprandi, G; Cirillo, I; Vizzaccaro, A1
Elser, I; Köhn, FM; Mempel, M; Ollert, M; Rakoski, J; Ring, J; Weidinger, S1
Fang, Q; Li, H; Wang, R; Yin, J; Zhang, H1
Attali, P; Bousquet, J; Leynadier, F; Murrieta, M1
Darnell, R; Stern, MA; Tudor, D1
Bousquet, J1
Blondin-Ertzbischoff, P; Emmerson, EB; Hardwicke, C; Judd, MS; Murrieta-Aguttes, M; Stern, M1
Attali, P; Ben-Soussen, P; Daele, J; Sabbah, A; Wade, AG1
Horak, F1
Bachert, C; Margari, P; Murrieta-Aguttes, M; Santoni, JP; Vovolis, V1

Reviews

1 review(s) available for mizolastine and Rhinitis, Allergic, Seasonal

ArticleYear
Clinical advantages of dual activity in allergic rhinitis.
    Allergy, 2000, Volume: 55 Suppl 64

    Topics: Anti-Allergic Agents; Benzimidazoles; Clinical Trials as Topic; Histamine H1 Antagonists; Humans; Hypersensitivity; Rhinitis; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal

2000

Trials

7 trial(s) available for mizolastine and Rhinitis, Allergic, Seasonal

ArticleYear
Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
    European annals of allergy and clinical immunology, 2004, Volume: 36, Issue:4

    Topics: Adult; Allergens; Anti-Allergic Agents; Benzimidazoles; Conjunctivitis, Allergic; Cytokines; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Interleukin-1; Interleukin-6; Male; Nasal Provocation Tests; Parietaria; Pollen; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Terfenadine; Tumor Necrosis Factor-alpha

2004
[Clinical examination of mizolastine in the seasonal allergic rhinitis].
    Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology, 2004, Volume: 18, Issue:8

    Topics: Adolescent; Adult; Aged; Benzimidazoles; Female; Histamine H1 Antagonists; Humans; Loratadine; Male; Middle Aged; Rhinitis, Allergic, Seasonal

2004
Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1996, Volume: 76, Issue:2

    Topics: Adult; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Rhinitis, Allergic, Seasonal

1996
Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season?
    Allergy, 1997, Volume: 52, Issue:4

    Topics: Adult; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Histamine H1 Antagonists; Humans; Male; Pollen; Rhinitis, Allergic, Seasonal; Seasons; Survival Analysis; Terfenadine; Time Factors; Treatment Outcome

1997
Rapid symptom relief in rhinitis.
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999, Volume: 29 Suppl 1

    Topics: Benzimidazoles; Double-Blind Method; Histamine H1 Antagonists; Humans; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Time Factors

1999
Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis.
    The Journal of international medical research, 1998, Volume: 26, Issue:6

    Topics: Adult; Benzimidazoles; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Rhinitis, Allergic, Seasonal; Treatment Outcome

1998
Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group.
    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 83, Issue:4

    Topics: Adolescent; Adult; Anti-Allergic Agents; Benzimidazoles; Cetirizine; Conjunctivitis, Allergic; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Safety; Time Factors; Treatment Outcome

1999

Other Studies

5 other study(ies) available for mizolastine and Rhinitis, Allergic, Seasonal

ArticleYear
[Antihistaminics. Side effects also after raising dosage at the placebo level].
    MMW Fortschritte der Medizin, 2003, May-29, Volume: 145, Issue:22

    Topics: Anti-Allergic Agents; Benzimidazoles; Butyrophenones; Cetirizine; Double-Blind Method; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Meta-Analysis as Topic; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal

2003
Anaphylaxis to mizolastine.
    The Journal of allergy and clinical immunology, 2004, Volume: 114, Issue:4

    Topics: Anaphylaxis; Benzimidazoles; Drug Hypersensitivity; Female; Histamine H1 Antagonists; Humans; Middle Aged; Rhinitis, Allergic, Seasonal

2004
[Allergic rhinitis. An antihistamine with dual effect also reduces obstruction].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1998, Volume: 49, Issue:3

    Topics: Benzimidazoles; Histamine H1 Antagonists; Humans; Nasal Obstruction; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal

1998
[Allergic rhinitis. Antihistamine with dual effect also reduces obstruction].
    HNO, 1998, Volume: 46, Issue:3

    Topics: Benzimidazoles; Histamine H1 Antagonists; Humans; Nasal Obstruction; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal

1998
Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).
    Allergy, 2001, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Benzimidazoles; Child; Cohort Studies; Conjunctivitis, Allergic; Europe; Female; Histamine H1 Antagonists; Humans; Incidence; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Treatment Outcome

2001